# A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

> **NCT00000824** · NA · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Lymphocytes, Activated

## Key facts

- **NCT ID:** NCT00000824
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** — (—)
- **Last updated:** 2016-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000824, "A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00000824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*